参考文献:1. Andreas K, Haupl T, Lubke C, Ringe J, Morawietz L, Wachtel A, Sittinger M, Kaps C (2009) Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration. Arthritis Res Ther 11:R15 CrossRef 2. Bamford J, Dennis M, Sandercock P, Burn J, Warlow C (1990) The frequency, causes and timing of death within 30聽days of a first stroke: the Oxfordshire Community Stroke Project. J Neurol Neurosurg Psychiatry 53:824鈥?29 CrossRef 3. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C (1991) Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337:1521鈥?526 CrossRef 4. Bessler H, Osovsky M, Beilin B, Alcalay Y, Sirota L (2007) The existence of gender difference in IL-1Ra gene polymorphism. J Interferon Cytokine Res 27:931鈥?35 CrossRef 5. Blakemore AI, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW (1994) Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 37:1380鈥?385 CrossRef 6. Castillo J, Alvarez-Sabin J, Martinez-Vila E, Montaner J, Sobrino T, Vivancos J (2009) Inflammation markers and prediction of post-stroke vascular disease recurrence: the MITICO study. J Neurol 256:217鈥?24 CrossRef 7. Chomarat P, Vannier E, Dechanet J, Rissoan MC, Banchereau J, Dinarello CA, Miossec P (1995) Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol 154:1432鈥?439 8. Cvetkovic JT, Wiklund PG, Ahmed E, Weinehall L, Hallmans G, Lefvert AK (2005) Polymorphisms of IL-1beta, IL-1Ra, and TNF-alpha genes: a nested case-control study of their association with risk for stroke. J Stroke Cerebrovasc Dis 14:29鈥?5 CrossRef 9. Dinarello CA (2000) The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. N Engl J Med 343:732鈥?34 CrossRef 10. Fischer E, Van Zee KJ, Marano MA, Rock CS, Kenney JS, Poutsiaka DD, Dinarello CA, Lowry SF, Moldawer LL (1992) Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 79:2196鈥?200 11. Francis SE, Camp NJ, Dewberry RM, Gunn J, Syrris P, Carter ND, Jeffery S, Kaski JC, Cumberland DC, Duff GW (1999) Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 99:861鈥?66 CrossRef 12. Haneda S, Nagaoka K, Nambo Y, Kikuchi M, Nakano Y, Matsui M, Miyake Y, Macleod JN, Imakawa K (2009) Interleukin-1 receptor antagonist expression in the equine endometrium during the peri-implantation period. Domest Anim Endocrinol 36:209鈥?18 CrossRef 13. Hurme M, Lahdenpohja N, Santtila S (1998) Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med 30:469鈥?73 CrossRef 14. Hyams JS, Fitzgerald JE, Wyzga N, Treem WR, Justinich CJ, Kreutzer DL (1994) Characterization of circulating interleukin-1 receptor antagonist expression in children with inflammatory bowel disease. Dig Dis Sci 39:1893鈥?899 CrossRef 15. Kang DW, Yoo SH, Chun S, Kwon KY, Kwon SU, Koh JY, Kim JS (2009) Inflammatory and hemostatic biomarkers associated with early recurrent ischemic lesions in acute ischemic stroke. Stroke 40:1653鈥?658 CrossRef 16. Kashyap RS, Nayak AR, Deshpande PS, Kabra D, Purohit HJ, Taori GM, Daginawala HF (2009) Inter-alpha-trypsin inhibitor heavy chain 4 is a novel marker of acute ischemic stroke. Clin Chim Acta 402:160鈥?63 CrossRef 17. Kriz J, Lalancette-Hebert M (2009) Inflammation, plasticity and real-time imaging after cerebral ischemia. Acta Neuropathol 117:497鈥?09 CrossRef 18. Lalouschek W, Schillinger M, Hsieh K, Endler G, Greisenegger S, Marculescu R, Lang W, Wagner O, Cheng S, Mannhalter C (2006) Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events. Clin Chem Lab Med 44:918鈥?23 CrossRef 19. Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MYI (2007) Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356:1517鈥?526 CrossRef 20. Lennard A, Gorman P, Carrier M, Griffiths S, Scotney H, Sheer D, Solari R (1992) Cloning and chromosome mapping of the human interleukin-1 receptor antagonist gene. Cytokine 4:83鈥?9 CrossRef 21. Lindsberg PJ, Grau AJ (2003) Inflammation and infections as risk factors for ischemic stroke. Stroke 34:2518鈥?532 CrossRef 22. Mansfield JC, Holden H, Tarlow JK, Di Giovine FS, McDowell TL, Wilson AG, Holdsworth CD, Duff GW (1994) Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 106:637鈥?42 23. Markus HS, Labrum R, Bevan S, Reindl M, Egger G, Wiedermann CJ, Xu Q, Kiechl S, Willeit J (2006) Genetic and acquired inflammatory conditions are synergistically associated with early carotid atherosclerosis. Stroke 37:2253鈥?259 CrossRef 24. Santtila S, Savinainen K, Hurme M (1998) Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 47:195鈥?98 CrossRef 25. Seripa D, Dobrina A, Margaglione M, Matera MG, Gravina C, Vecile E, Fazio VM (2003) Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke. Cerebrovasc Dis 15:276鈥?81 CrossRef 26. Skinner RA, Gibson RM, Rothwell NJ, Pinteaux E, Penny JI (2009) Transport of interleukin-1 across cerebromicrovascular endothelial cells. Br J Pharmacol 156:1115鈥?123 CrossRef 27. Steinbrugger I, Haas A, Maier R, Renner W, Mayer M, Werner C, Wedrich A, El-Shabrawi Y, Schmut O, Weger M (2009) Analysis of inflammation- and atherosclerosis-related gene polymorphisms in branch retinal vein occlusion. Mol Vis 15:609鈥?18 28. Syrjanen J, Valtonen VV, Iivanainen M, Kaste M, Huttunen JK (1988) Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients. Br Med J (Clin Res Ed) 296:1156鈥?160 CrossRef 29. Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, Duff GW (1993) Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 91:403鈥?04 CrossRef 30. Tso AR, Merino JG, Warach S (2007) Interleukin-6 174G/C polymorphism and ischemic stroke: a systematic review. Stroke 38:3070鈥?075 CrossRef 31. Weyrich AS, Skalabrin EJ, Kraiss LW (2009) Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole. Am J Ther 16:164鈥?70 CrossRef 32. Witkin SS, Gerber S, Ledger WJ (2002) Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 34:204鈥?09 CrossRef 33. Wood PH (1980) Appreciating the consequences of disease: the international classification of impairments, disabilities, and handicaps. WHO Chron 34:376鈥?80 34. Worrall BB, Azhar S, Nyquist PA, Ackerman RH, Hamm TL, DeGraba TJ (2003) Interleukin-1 receptor antagonist gene polymorphisms in carotid atherosclerosis. Stroke 34:790鈥?93 CrossRef 35. Worrall BB, Brott TG, Brown RD Jr, Brown WM, Rich SS, Arepalli S, Wavrant-De Vrieze F, Duckworth J, Singleton AB, Hardy J, Meschia JF (2007) IL1RN VNTR polymorphism in ischemic stroke: analysis in 3 populations. Stroke 38:1189鈥?196 CrossRef 36. Xu S, Huang W, Qian J, Jin L (2008) Analysis of genomic admixture in Uyghur and its implication in mapping strategy. Am J Hum Genet 82:883鈥?94 CrossRef 37. Yamada Y, Ichihara S, Nishida T (2008) Proinflammatory gene polymorphisms and ischemic stroke. Curr Pharm Des 14:3590鈥?600 CrossRef 38. Zeller JA, Lenz A, Eschenfelder CC, Zunker P, Deuschl G (2005) Platelet-leukocyte interaction and platelet activation in acute stroke with and without preceding infection. Arterioscler Thromb Vasc Biol 25:1519鈥?523 CrossRef
作者单位:Yeqing Tong (1) (2) (3) Jinjun Han (4) Xuhua Guan (1) Zuxun Lu (2) Xiaoping Miao (2) Jianjun Ye (1) Shuang-yi Hou (1) Yanwei Zhang (3) Yijie Geng (3) Yang Li (1) Faxian Zhan (1) Jiafa Liu (1) Jin-quan Cheng (3)
1. Hubei Center for Disease Control and Prevention, Wuhan, 430079, China 2. School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China 3. Key Laboratory of Molecular Biology of Guangdong Province, Shenzhen Center for Disease Control and Prevention, Shenzhen, 518020, China 4. Department of Thoracic and Cardiovascular Surgery, Guang Dong Medical College FuTian Hospital, Shenzhen, 518055, China